"diabetes"

New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the future.

GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several different types of tu...

'The Pitt' leads Emmy nominations with 25 nods, but the medical drama's bigger achievement is teaching millions of Americans about health an...

In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI’s healthcare push, Vertex’s $10 billion...

A new study suggests inexpensive AI could reshape healthcare’s business model by helping patients use LLMs to manage and improve their healt...

The Trump administration is closing a loophole that drugmakers could use to avoid negotiations when they add active ingredients to drugs. It...

The U.S. spends a lot on healthcare — in terms of total and per capita expenditures and patient out-of-pocket costs — but gets a relatively...

One could argue if the rule changes being implemented by the Trump administration represent a further hollowing out of ACA in lieu of a Cong...

According to a new study, GLP-1s may be potentially effective in reducing chronic inflammation.

GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the biggest contributor to rising prescription spending. And that will trigger...

Helping people make informed decisions may ultimately create more value than providing additional information.

The best Medicare plan is not always the cheapest. It is the one that still works when your health needs change.